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Mitochondrial dynamics is a recent topic of research in the field of cardiac physiology.
The study of mechanisms involved in the morphological changes and in the mobility
of mitochondria is legitimate since the adult cardiomyocytes possess numerous
mitochondria which occupy at least 30% of cell volume. However, architectural constraints
exist in the cardiomyocyte that limit mitochondrial movements and communication
between adjacent mitochondria. Still, the proteins involved in mitochondrial fusion and
fission are highly expressed in these cells and could be involved in different processes
important for the cardiac function. For example, they are required for mitochondrial
biogenesis to synthesize new mitochondria and for the quality-control of the organelles.
They are also involved in inner membrane organization and may play a role in apoptosis.
More generally, change in mitochondrial morphology can have consequences in the
functioning of the respiratory chain, in the regulation of the mitochondrial permeability
transition pore (MPTP), and in the interactions with other organelles. Furthermore, the
proteins involved in fusion and fission of mitochondria are altered in cardiac pathologies
such as ischemia/reperfusion or heart failure (HF), and appear to be valuable targets for
pharmacological therapies. Thus, mitochondrial dynamics deserves particular attention
in cardiac research. The present review draws up a report of our knowledge on these
phenomena.
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INTRODUCTION
Mitochondria, which have long been regarded only as energy
producers, are actually recognized at the crossroads of many cel-
lular functions. Obviously, they play a crucial role in energy
production in cells, but they are involved in other phenomena
such as ion homeostasis, free radical production, and ultimately
cell death. Many of their characteristics, as morphology, loca-
tion in the cell, proximity to other organelles are important
parameters that have to be considered to understand the mito-
chondrial functions. This is particularly true in the adult cardiac
cells where mitochondria, which produce 90% of ATP, occupy
30% of cardiac cell volume and are embedded in a dense and
complex organization. This interlinking reflects the challenging
function of the heart which requires rhythmic contractions of
the pump throughout the life, and consequently needs a fast
and effective intracellular energy delivery to the ATP consumers
of the cardiomyocyte (for review, see Ventura-Clapier et al.,
2011). Moreover, the main phosphorylated metabolites do not
vary with the increase in work (Balaban, 2012). This metabolic
homeostasis and the tight coupling between mitochondria and
ATP consumer sites are two of the peculiarities of the cardiac
cell and require an optimized cellular organization to ensure
efficient energy fluxes. Any modification of the cellular archi-
tecture, but also of the internal organization of mitochondria
could thus impair cell energetic and as a consequence cell
function.
In the majority of cells, mitochondria are able to adjust their
morphology and their location depending on energy needs and
metabolic conditions (Hackenbrock, 1966; Bereiter-Hahn, 1990;
Karbowski and Youle, 2003; Rossignol et al., 2004; Mannella,
2006; Benard et al., 2007; Soubannier and McBride, 2009). This
“mitochondrial dynamics” seems to be particularly important
during cell division and for mitochondrial quality control; it
may also play a role under pathological conditions. At some
point, mitochondrial network morphology actually is the result
of several processes, including fusion and fragmentation of the
organelles which are usually controlled by a complex protein
machinery (for review, see Liesa et al., 2009). It is generally
admitted that a connected mitochondrial network is observed
in active metabolic cells (Skulachev, 2001) while the mitochon-
dria are rather fragmented in quiescent cells (Collins et al., 2002).
However, it should be kept in mind that mitochondria exhibit
a high structural and functional tissue specificity in connection
with cell functions. Thus, any finding on mitochondrial orga-
nization and functioning cannot be directly extrapolated before
being considered in the framework of the considered cell or tissue.
For example in adult cardiac cells, the relationship between mito-
chondrial morphology and function does not seem to be rigorous,
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since cardiomyocytes are metabolically active but exhibit an
apparently fragmented network (Kuznetsov et al., 2009).
Mitochondrial dynamics, however, depends on the cellular
environment and architecture constraints. In adult cardiomy-
ocytes, the large amount of myofilaments, the presence of a
rigid cytoskeleton and the densely packed mitochondrial network
clearly impedes mitochondrial movements (Vendelin et al., 2005).
Moreover, the arrangement of the different organelles between
them is so crucial for cardiac cell function that mitochondrial
morphology has to be efficiently controlled (Wilding et al., 2006;
Piquereau et al., 2010). Although abundance of proteins of the
mitochondrial dynamics can appear paradoxical in cardiac cells,
where the mitochondrial network appears to be frozen, it may
be less rigid than believed. Proteins of the mitochondrial dynam-
ics are involved in multiple processes and can thus be important
for cardiac physiology out of their role in mitochondrial network
organization. In this review, we present some evidences for the
importance of these proteins in physiological and pathological
situations.
MITOCHONDRIAL FUNCTIONS IN THE ADULT CARDIAC
CELL: TANGLED IN A COMPLEX ARCHITECTURE
ROLE OF THE INTERNAL ORGANIZATION OF MITOCHONDRIA
Since the discovery of the chemiosmotic mechanism of ATP
synthesis by PD Mitchell in the 1960s, the importance of mito-
chondrial internal organization and of a local regulation of energy
production has been pointed out by many authors. Indeed,
organization of internal membranes of mitochondria is criti-
cal for an optimal function of respiratory complexes and ATP
formation (Davies et al., 2011). The existence of a large inner
membrane folded in cristae, where oxidative-phosphorylation
coupling occurs, is a prerequisite for local proton gradient genera-
tion andmaximal ATP synthase functioning (Strauss et al., 2008).
Phospholipids, and in particular cardiolipins, are involved in the
formation of these cristae (Khalifat et al., 2008). However, the
all set of elements inducing cristae generation is far from being
elucidated. For example, the presence of oligomers of ATP syn-
thase (Davies et al., 2012) and of dynamin proteins (Hinshaw,
2000) could also play a role in the cristae organization. Different
dynamin proteins, such as the optic atrophy protein 1 (Opa1)
or Mitofilin, have been recognized as important actors regu-
lating cristae formation (Frezza et al., 2006; Hoppins et al.,
2011a). Those cristae are dynamic structures which can rapidly
and reversibly fuse and divide, depending on energetic state
(Mannella, 2006), from orthodox to condensed conformations
upon activation of ATP synthesis (Hackenbrock, 1966; Mannella,
2008). Thus, optimal mitochondrial function seems to require
the morphological control of inner membrane organization. This
is particularly evident for mitochondria of the adult cardiomy-
ocyte that exhibit the highest density of cristae (Vafai andMootha,
2012). Finally, it is also well-known that changes in mitochon-
drial morphology can play a role in different events, in particular
in mitochondrial permeability transition pore (MPTP) function,
and in apoptosis (Nogueira et al., 2005; Wasilewski and Scorrano,
2009; Campello and Scorrano, 2010). So it is now evident that
all the phenomena that modify mitochondrial morphology can
modify mitochondrial functions, and possibly cell functions.
Another important feature of mitochondria, especially in car-
diac cells, is the existence of local control of energy production
in the intermembrane space by different phosphotransfer enzyme
systems. For example, we and others have shown that the mito-
chondrial creatine kinase isoform (miCK), which is located in
the vicinity of the adenine nucleotide translocase (ANT), allows
a local supply of ADP, a local control of proton concentration,
and an efficient transfer of energy via phosphocreatine (PCr)
diffusion (Joubert et al., 2000, 2001a, 2002a; Saks et al., 2000;
Guzun et al., 2012). Such enzymes also play a role in the structural
organization of the intermembrane space by bridging inner and
outer membranes (Wallimann et al., 1992; Speer et al., 2005). Any
modification of this energetic microdomain organization by alter-
ation of mitochondrial morphology could affect local regulation
of energy production.
IMPORTANCE OF CELL ARCHITECTURE FOR ENERGY TRANSFER AND
COMMUNICATION BETWEEN ORGANELLES
Adult cardiomyocytes are characterized by a complex cytoarchi-
tecture which allows an efficient and synchronized contraction of
the entire cell. Themaintenance of this cytoarchitecture is ensured
by the cytoskeleton which holds sarcomeres in lateral register,
mechanically couples myofibrils of adjacent myocytes, and trans-
duces mechanical stress signals. Mitochondria are an integral part
of this cytoarchitecture; different populations of those organelles
are usually defined according to their location: intermyofibril-
lar mitochondria, subsarcolemmal mitochondria and perinuclear
mitochondria. Those mitochondria are easily identifiable by elec-
tron microscopy (Figure 1). Intermyofibrillar mitochondria are
strictly ordered between rows of contractile proteins, apparently
isolated from each other by repeated arrays of T-tubules, and in
close contact with myofibrils and sarcoplasmic reticulum (SR)
(Vendelin et al., 2005; Kuznetsov et al., 2009; Guzun et al., 2012);
they are mainly devoted to the energy supply of myosin and
FIGURE 1 | Image of adult mouse cardiomyocyte obtained by electron
microscopy. Three subpopulations of mitochondria are observed:
intermyofibrillar mitochondria (IM) along the contractile proteins, the
subsarcolemmal mitochondria (SM) just beneath the sarcolemmal and
perinuclear mitochondria (PN) around the nucleus. m, myofibrils; n, nucleus.
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SR-ATPases. The subsarcolemmal mitochondria present a lower
degree of organization and are probably mainly involved in other
roles such as ion homeostasis or signaling pathways. Finally, per-
inuclear mitochondria are organized in clusters and are most
probably involved in transcription and translation processes.
Concurrently to these functional differences, those mitochondria
do not exhibit exactly the same morphology; for example, some
authors have shown that intermyofibrillar mitochondria can be
larger in certain situations (Ong et al., 2010).
Thus, the mitochondria in muscle cells seem separated from
each other and exhibit a unique feature of a highly ordered
crystal-like structure which appears optimized for maximal effi-
cacy of energy supply and sustained contraction (Vendelin et al.,
2005). Due to spatial constraints and isolation of mitochondria
from each other, the energetic regulation of contraction would be
confined in the small regions surrounding each sarcomere where
the intracellular components interact with each other and com-
pose the Intracellular Energetic Units (ICEU) (Saks et al.,
2001; Guzun et al., 2012). The family of creatine kinases (CK),
specifically located on the inner-membrane of the mitochon-
drion, but also at the M-line of myofibrils and on the outer
surface of the SR, is an important component of these ICEUs and
allows efficient local control over adenine nucleotides and fast
energy transfer (Joubert et al., 2001b, 2002b; Tepp et al., 2011),
thus emphasizing the importance of subcellular organization and
compartmentalization of energy transfer (Joubert et al., 2002c;
Piquereau et al., 2010).
Another evidence of the importance of cardiac cell architec-
ture is the existence of microdomains of Ca2+ at the interface
of the organelles. Different authors have shown that the close
association between mitochondria and SR provides “hot spots”
of very high calcium concentration in the vicinity of mitochon-
dria (Dorn and Maack, 2013). At energetic level, the existence
of direct adenine nucleotide canalization (DANC) (Kaasik et al.,
2001) has also been shown to represent a pathway complemen-
tary to phosphotransfer enzymes to directly transfer and regulate
ATP and ADP levels in microdomains at the interface of the
organelles. Interestingly, this cytoarchitecture develops at the time
of early cardiac ontogenic development (Piquereau et al., 2010),
and when disturbed, the efficiency of this direct canalization is
decreased (Wilding et al., 2006). Moreover, a change in osmotic
pressure which can induce swelling or shrinkage of mitochondria
can modulate the function of other compartments (Kaasik et al.,
2004, 2010). Any change of cell architecture, and particularly
of mitochondrial morphology, can therefore impact mitochon-
drial function and energy transfer (Joubert et al., 2008; Piquereau
et al., 2012). This is why many authors address the question of
how mitochondrial dynamics play a regulatory role in energy
production and cell signaling in the heart.
MITOCHONDRIAL DYNAMICS PROTEINS IN THE HEART
Mitochondria are dynamic organelles able to change their mor-
phology in response to different signals. Phenomena that govern
mitochondrial morphology aroused real interest since the 1970s
when the first fusion events have been described (Kimberg and
Loeb, 1972; Wakabayashi et al., 1975; Wakabayashi and Green,
1977). For the last four decades, the mechanistic knowledge of
mitochondrial dynamics has been well-developed and, even if
some phenomena involved in mitochondrial fusion and fission
remain shrouded in mystery, the major proteins governing these
processes have been identified. The complete protein machinery
of mitochondrial fusion and fission exists in cardiac cells and
specifically regulates mitochondrial morphology and size. The
currently identified of such proteins and their possible roles in
the adult heart are summarized next.
PROTEINS INVOLVED IN FUSION AND FISSION OF MITOCHONDRIA
All studies agree so far that fusion of the outer and inner mito-
chondrial membranes occurs separately and involves distinct
molecules. The outer membrane fusion is governed by mito-
fusins (Mfn1 and Mfn2) (Santel and Fuller, 2001; Legros et al.,
2002) while the innermembrane fusion involvesOpa1 (Alexander
et al., 2000). Interestingly, these two kinds of proteins (Mfns
and Opa1) exhibit strong similarities in their structure and their
mode of action. Indeed, these proteins contain a GTPase domain,
a transmembrane domain allowing the anchorage of the pro-
teins to the outer (Mfns) or inner (Opa1) membranes, and a
coiled-coil domain.Whereas their GTPase domain implies a GTP-
dependence of the phenomena involved in the mitochondrial
fusion (Chen et al., 2003; Ishihara et al., 2004; Olichon et al.,
2007), the coiled-coil domain also plays a major role since it
allows homotypic (Mfn1-Mfn1, Mfn2-Mfn2 et Opa1-Opa1) or
heterotypic (Mfn1-Mfn2) interaction of these proteins (Chen
et al., 2003). The non-transmembrane part of Mfns, which is
located in the cytosol, allows, through the interaction of the
coiled-coil domains of two distinct Mfn proteins, the formation
of a physical link between the outer membranes of two neigh-
boring mitochondria (Koshiba et al., 2004; Chan, 2006). Thus,
these two outer membranes become closer and the fusion of the
involved mitochondria is initiated. In a similar way, the forma-
tion of Opa1-Opa1 homotypic complexes leads to the fusion of
the inner membranes of the mitochondria engaged in the fusion
process (for review see Liesa et al., 2009).
The specificity of action of these proteins is partly due to their
anchorage to the membranes of which they control the fusion.
However, the specific localization of each protein does not seem
to be exclusive since Opa1 exists in a soluble form, which has been
detected in an isolated outer mitochondrial membrane fraction,
indicating that this Opa1 isoform is able to interact with the outer
membrane (Satoh et al., 2003). Besides, this observation com-
bined to the description of a direct interaction between Mfns and
Opa1 (Guillery et al., 2008) could in part explain the synchroniza-
tion of Mfns and Opa1 action. Indeed, the coordination of these
proteins is still mysterious because no clear mechanism has been
claimed and no equivalent to Ugo1, the yeast protein known to be
involved in the coordination of Mfns and Opa1 yeast orthologs
(Fzo et Mgm1, Hales and Fuller, 1997; Alexander et al., 2000), has
been described in mammals.
Whereas the mechanisms involved in mitochondrial fusion
seem to be relatively well-understood, the processes regulating
mitochondrial fission still raise some questions. During the end
of the 1990s and the beginning of the 2000s, many studies were
interested in the dynamin-related protein 1 (Drp1), also called
Dynamin-like protein 1 (Dlp1), and the mitochondrial fission
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protein 1 (Fis1), which were considered as the major actors of
mitochondrial fission. Drp1 is a cytosolic protein which com-
prises a GTPase domain and migrates to mitochondria using
dynein and the microtubule (Varadi et al., 2004) or the actine
network (De Vos et al., 2005), depending on the fission initi-
ating factor. After this migration, Drp1 is specifically found at
the level of the future fission site where it oligomerizes to form
a ring, the GTP-dependence constriction of this ring leading to
mitochondrial division (Yoon et al., 2001; Ingerman et al., 2005).
Interestingly, while phosphorylated Drp1 stays inactive in the
cytosol, Drp1 activity can be modulated by calcium through the
activation of calcineurin which participates in Drp1 mitochon-
drial recruitment by dephosphorylating it. This mechanism could
be of high significance in muscle cells where calcium is cyclically
released from the SR (Cribbs and Strack, 2007; Cereghetti et al.,
2008). Knowing that this protein does not exhibit any transmem-
brane domain necessary for its anchorage to the mitochondrial
membranes, its mitochondrial localization requires a docking
receptor on the outer mitochondrial membrane. Fis1 was the
first protein described as the mitochondrial receptor (Yoon et al.,
2003). Fis1 which is anchored in the outer mitochondrial mem-
brane has an intracellular facing domain containing five α-helices
which allow oligomerization (for the first α-helix) and direct or
indirect interaction with Drp1 (for the all set of α-helices) (Jofuku
et al., 2005).
Although many experimental studies have established an
undeniable role of Fis1 in mitochondrial fission, the recruitment
of Drp1 to mitochondria is not affected by Fis1 deficiency (Lee
et al., 2004; Wasiak et al., 2007). Thus, Fis1 does not appear to
be the only factor involved in Drp1 mitochondrial recruitment.
Three other proteins have been described like the mitochon-
dria fission factor (Mff) (Otera et al., 2010), the mitochondrial
dynamics protein of 49 kDa (MiD49) or 51 kDa (MiD51) (Palmer
et al., 2011). As Fis1, these three proteins are anchored to the outer
mitochondrial membrane (Gandre-Babbe and van der Bliek,
2008; Palmer et al., 2011). The involvement of each protein in
mitochondrial fission is, however, not yet clearly defined, and
the interaction of these proteins with Drp1 could require other
intermediary proteins. This is the case in the yeast in which the
interaction of Drp1 and Fis1 orthologs needs several other pro-
teins like Mdv1 and Caf4 (Tieu et al., 2002; Griffin et al., 2005);
however, no such proteins have been described inmammals so far.
If a specific machinery of the inner mitochondrial membrane
fission exists, it remains unknown. Although, it is suggested that
the MDM33 protein is involved in the fission of the inner mem-
brane of Saccharomyces cerevisae mitochondria (Messerschmitt
et al., 2003), no MDM33 ortholog has been found in mam-
mals. Even if a study proposes that a protein called Mtp18
(Mitochondrial protein 18) could be an actor of this unknown
innermitochondrial membrane fissionmachinery (Tondera et al.,
2005), this clearly requires further investigations.
Finally, mechanisms governing mitochondrial fragmentation
seem to be less specific than those involved in mitochondrial
fusion. Indeed, Drp1, Fis1, and Mff which are responsible for
mitochondrial fission are also implicated in peroxisome fission
(Koch et al., 2003, 2005; Gandre-Babbe and van der Bliek, 2008);
however, the synchronization or the joint regulation of these two
phenomena has never been explored. The fact that the fission of
these two organelles involves the same proteins should not be
coincidental. It can be noticed that mutations in genes encoding
these proteins have been involved in serious diseases, and in par-
ticular in neurological diseases such as Charcot-Marie-Tooth type
2A or autosomal dominant optic atrophy (ADOA) (Alexander
et al., 2000; Delettre et al., 2001; Zuchner et al., 2004). In heart
failure (HF), recent data also suggest their possible implication in
the progression of the pathology (Chen et al., 2009), suggesting a
role of these proteins in cardiac tissue.
WHAT ABOUTMITOCHONDRIAL DYNAMICS IN THE HEART?
Whereas it has long been suggested that adult cardiomyocytes
would show a limited mitochondrial dynamics because of the
complex cytoarchitecture of this cell, the high expression level of
dynamin proteins in the heart (Alexander et al., 2000; Delettre
et al., 2001; Santel et al., 2003; Gandre-Babbe and van der Bliek,
2008) implies that these actors could play roles which would not
be anecdotal. Thus, many research groups have tried to explain
mitochondrial dynamics in the heart for a few years. However,
knowing that the initial experiments were done with immortal-
ized cardiac cell lines (H9c2, HL-1) or with neonatal cardiomy-
ocytes (Shen et al., 2007; Parra et al., 2008; Twig et al., 2008a) in
which mitochondria face an environment very different from the
adult one (Leu et al., 2001; Piquereau et al., 2010), the first data
about mitochondrial fusion and fission obtained in the mature
heart are relatively new and consequently these phenomena are
not clearly understood yet.
Existence of mitochondrial dynamics in the adult heart
Mitochondrial dynamics comprises two main notions, one is the
capacity of mitochondrial to move within the cell and the sec-
ond relates to the capacity to undergo fusion and fission, these
two notions not being mutually exclusive. As presented above, the
adult cardiac muscle cell is an extremely organized cell in which
the mitochondrial movements are greatly restricted (Beraud
et al., 2009; Hom and Sheu, 2009). Moreover, the fusion/fission
events appear to be greatly slowed compared to neonatal car-
diomyocytes, and mitochondria are poorly connected. It has
been recently suggested that the fusion/fission cycle would last
14–16 days in adult cardiomyocytes (Chen et al., 2011). Thus,
mitochondrial dynamics could seem irrelevant, although mito-
chondria have a limited life span, being subjected to biogene-
sis and autophagy/mitophagy, which are strictly dependent on
fusion and fission phenomena (Diaz and Moraes, 2008; Twig
et al., 2008b). Consequently, even if fusion or fission events have
never been observed in real time, this mitochondrial turnover
imposes mitochondrial dynamics as an essential cog of cardiac
physiology.
Phenotypic examination of genetically modified mice has
recently substantiated our knowledge. Major changes in mito-
chondrial morphology have been described in mice with
inducible cardiac Mfn2 ablation (Papanicolaou et al., 2011),
or decrease in Opa1 protein content (Piquereau et al., 2012).
However, the observation of larger mitochondria in Mfn2 and
Opa1 deficient mice made by Walsh’s group (Papanicolaou et al.,
2011) and our team (Piquereau et al., 2012) is surprising because
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it contradicts the previously published data. Indeed, while sev-
eral studies on non-cardiac cells (Chen et al., 2003; Olichon et al.,
2003; Yoon et al., 2003; Cipolat et al., 2004; Stojanovski et al.,
2004; Griparic et al., 2007) evidenced that a decrease in expres-
sion of a fusion protein would lead, respectively, to mitochondrial
network fragmentation, in these animal studies, deficiency in
the fusion proteins Mfn2 or Opa1 led to paradoxically larger
cardiac mitochondria. Thus, it appears that the specific archi-
tectural organization of this cell impact on the phenomena and
presumably affects the mode of action of these proteins. On the
other hand, the cardiac-specific Mfn1-null mice showed a frag-
mentation of the mitochondrial network (Papanicolaou et al.,
2012); this observation reinforces the idea that Mfn1 and Mfn2
play different roles. Finally, the conditional combinedMfn1/Mfn2
ablation in adult hearts induces mitochondrial network fragmen-
tation (Chen et al., 2011). Thus, mitochondrial dynamics exists
in the heart tissue, but is a complex process that depends on the
specific cell architecture.
Beyond the fact that these genetically-manipulated mice show
obvious changes in cardiac mitochondrial morphology, signif-
icant deleterious consequences on their cardiac function were
observed under stress (Papanicolaou et al., 2011; Piquereau et al.,
2012), suggesting a direct involvement of the mitochondrial mor-
phology in the heart function. At present, it is complicated to
determine how and to which extent themorphology ofmitochon-
dria affects cardiac efficiency. For example, our group has already
evidenced that changes in the mitochondrial volume may directly
impact the force developed by myofibrils (Kaasik et al., 2004) as
well as the direct energetic transfers between mitochondria and
myofilaments (Piquereau et al., 2012). Even if these studies are
insufficient to conclude that these mechanisms are responsible for
the cardiac alterations observed in the previously described mod-
els, they suggest a direct link between mitochondrial morphology
and cardiac contractile function. However, it is not easy to get an
overall understanding of the mechanisms governing mitochon-
drial fusion and fission in the heart, even if it obviously seems
that mitochondrial dynamics exists in this organ on a very slow
time-course in the normal heart.
Impact of mitochondrial dynamics alterations on respiratory
capacities
It is generally accepted that fusion-fission processes impact on
the mitochondrial energetics in cultured cells (Chen et al., 2003).
Disruption of mitochondrial dynamics by overexpression or sup-
pression of fusion (Mfn2, Opa1) (Olichon et al., 2003; Chen et al.,
2005) or mitochondrial fission (Benard et al., 2007), can cause
alterations in mitochondrial metabolism (Chen and Chan, 2005),
according to the degree of differentiation of the considered cell
type. These changes may be accompanied by the modulation of
the mitochondrial membrane potential, and of the expression of
complex I, IV, and V subunits (Pich et al., 2005; Chan, 2006;
Liesa et al., 2009). However, in patients and in mouse models,
direct effect of dynamin mutations on mitochondrial function
gave conflicting results, probably because of the diversity of the
cell types and themutations studied (Olichon et al., 2006). In gen-
eral, it is considered that fragmentation induced by an increase
in Drp1 or a decrease in Mfn2 or Opa1 is harmful and leads
to metabolic disorders (Parra et al., 2011). In contrast, fusion is
generally considered rather beneficial. But a careful look at the
literature shows that there is no clear link between mitochondria
morphology and respiratory capacities, especially in mature car-
diac cell. Indeed, in three different studies, no obvious alterations
of respiratory chain function were observed when Opa1, Mfn1
orMfn2were separately genetically downregulated (Papanicolaou
et al., 2011, 2012; Piquereau et al., 2012), except for free fatty-acid
utilization in Opa1+/− mice (Piquereau et al., 2012). In another
study where a different Opa1 mutation was studied, mitochon-
drial function alterations were only observed in old mice (Chen
et al., 2012). Finally, when complete/double KO (Mfn1/Mfn2)
was used to suppress fusion proteins, decreased oxygen consump-
tion or increased oxidative stress was observed (Chen et al., 2011;
Dorn et al., 2011). Thus, compensatory mechanisms with other
dynamin proteins may exist and attenuate the consequences of
one dynamin protein deficiency, but complete loss or aging will be
detrimental for mitochondrial function. In addition to an effect
on respiratory chain function, other mitochondrial functions can
also be affected by mitochondrial dynamics protein alterations.
Implication in mitochondrial biogenesis
As mentioned above, the mechanisms involved in mitochondrial
dynamics in the cardiomyocyte seem not to be exactly similar
to those observed in proliferative cells. However, this complex-
ity is easily understood when the cardiomyocyte is regarded as
a cell presenting a strictly organized intracellular architecture
which is not in favor of mitochondrial plasticity as in divid-
ing cells. It is thus important to keep in mind this notion when
extrapolating results obtained during the early development to
adulthood. Obviously, the role of mitochondrial dynamics is dif-
ferent in prenatal and neonatal cardiomyocytes which proliferate
and consequently need the synthesis of new mitochondria to
assure a suitable repartition of these organelles between daughter
cells obtained after mitosis, and in non-dividing adult cardiomy-
ocytes. Not surprisingly, we already described a remarkably high
level of expression of mitochondrial biogenesis and dynamics
genes during the early stages of postnatal development in the
heart (Piquereau et al., 2013). Thus, this important stimulation of
mitochondrial biogenesis and therefore of mitochondrial dynam-
ics during development could explain why the cardiac-specific
ablation of dynamins during prenatal or early postnatal devel-
opment quickly leads to HF and death while several months are
needed when the ablation occurs at the beginning of adulthood
(Chen et al., 2011; Papanicolaou et al., 2012; Dorn, 2013). More
generally, this could explain the lethality of the total dynamin
knock-out models which die in utero (Alavi et al., 2007; Chen
et al., 2011), a period during which the mitotic activity is undeni-
ably substantial.
Globally, it would seem that mitochondrial dynamics is par-
ticularly important when the heart is under conditions which
require the synthesis of new mitochondria. This is the case dur-
ing development, but also in stress conditions like ischemia
(Ong et al., 2010) or pressure overload (Piquereau et al., 2012)
or ageing (Chen et al., 2012) which induce increased energetic
demand and mitochondrial damages and consequently requires
an adequate mitochondrial turnover. That is certainly the reason
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why the mice genetically manipulated to abolish Mfn2 expres-
sion or to decrease Opa1 expression exhibit a high sensitivity to
stress. This highlights the fact that the reduced mitochondrial
dynamics can be partly compensated under baseline conditions
while under stress the mitochondrial turnover cannot be ensured
and precipitates cardiac dysfunction. Finally, inducible cardiac-
specific double ablation of Mfn1 and Mfn2 genes quickly led to
dilated cardiomyopathy before inducing death within 9 weeks
after gene ablation. Interestingly, the heterozygous mutation of
the Drp1 gene also induced a dilated cardiomyopathy in mice
(Ashrafian et al., 2010). The cardiac dysfunction observed in these
genetically-manipulated mice clearly shows that these proteins
play a fully-fledged role in cardiac muscular cell physiology.
Other roles of mitochondrial dynamics proteins
All dynamins described above are of course widely known for the
role they play in mitochondrial dynamics; however, these pro-
teins could have a broader field of action than it seems (Figure 2).
Several studies assigned them an effect on the property of the
MPTP, a non-selective pore which induces, in particular situa-
tions, a high permeability of the mitochondrial membranes and
can lead to cell death (Di Lisa and Bernardi, 2009). Indeed, we and
others showed that the adult cardiomyocytes partially deficient in
Opa1 (Piquereau et al., 2012) or totally deficient in Mfn1 or Mfn2
(Papanicolaou et al., 2011, 2012) exhibit a delayed Ca2+-induced
MPTP opening. Knowing that these observations have been
obtained in isolated cardiomyocytes with enlarged or fragmented
mitochondria, they suggest that the individual volume of the
mitochondria are not directly involved and that Opa1 and mito-
fusins could facilitate MPTP opening under normal conditions.
Themechanisms leading to this protection are far from being elu-
cidated. Moreover, the data obtained from adult heart deficient
in the two mitofusins, which did not show any change in MPTP
sensitivity in comparison with wild type (Chen et al., 2011), com-
plicate the understanding even if the experimental conditions
differ (isolated mitochondria vs. cardiomyocytes).
Whereas their involvement in the prevention of MPTP open-
ing could indirectly confer to Opa1 and mitofusins an indirect
role in cardiomyocyte death, it seems, however, that the role of the
mitochondrial dynamics proteins in cell death is not really clear.
It is well-known that mitochondria are central elements in cell
death, and a link between mitochondrial network fragmentation
and apoptosis has been already described in cell lines (Frank et al.,
2001; Breckenridge et al., 2003) and in neonatal cardiomyocytes,
suggesting an important role of fission protein, especially Drp1
(Parra et al., 2008; Wakabayashi et al., 2009), in this form of cell
death. The fusion proteins could also be directly involved in cell
death by acting in an original way. Even if the data obtained from
studies realized with cell lines assert that fusion is prosurvival
while fission is proaptotic, Mfn2 could participate in apopto-
sis. The participation of Mfn2 to this particular death has been
demonstrated in cardiomyocytes and smooth muscle cells (Guo
et al., 2007; Shen et al., 2007). The details of this mechanism are
still unclear, although an interaction between Mfn2 and the pro-
apoptotic protein Bax has been described (Hoppins et al., 2011b).
On the other hand, Opa1 would have an opposite role and could
be an antiapoptotic factor. Indeed, this protein would regulate cell
death by forming oligomers of two Opa1 proteins creating a “bot-
tle neck”-like structure which allows cytochrome c sequestration
in the cristae (Frezza et al., 2006). By this oligomerization, Opa1
FIGURE 2 | Scheme summarizing the potential roles of mitochondrial dynamics proteins in the adult cardiomyocyte.
Frontiers in Physiology | Mitochondrial Research May 2013 | Volume 4 | Article 102 | 6
Piquereau et al. Mitochondrial dynamics in the heart
is in fact a crucial protein in the mitochondrial internal organiza-
tion which is, as stated above, essential for the functions of these
organelles.
Thus,mitochondrial dynamics proteins are clearly essential for
the adaptation of those organelles to cell status. Moreover, some
of them could be at the heart of the interaction between mito-
chondria and other components of the cell. Indeed, Mfn2, but not
Mfn1, is also found at the endoplasmic reticulum (ER)membrane
and thus can create physical links between ER and mitochondria
(de Brito and Scorrano, 2008). This link has been recently shown
between mitochondria and SR in muscle cells (Dorn and Maack,
2013); considering the calcium and energetic microdomains at
the interface of mitochondria and SR described in the cardiomy-
ocytes, Mfn2 could be a major actor of the contractile function of
the heart.
Moreover, the physical links between ER and mitochondria
were demonstrated to increase following ER stress (Csordas et al.,
2006), a specific response triggered when ER homeostasis is
disrupted and ER function is compromised. In the heart, ER
stress has recently been recognized as an important contributor
to the development of cardiac dysfunction (Groenendyk et al.,
2013), and the link between ER stress and Mfns has started to
be investigated. By using knock-out mice, Ngoh and colleagues
demonstrated that cardiomyocyte-specific deletion of Mfn2, but
not Mfn1, induces ER stress in vivo, leading to the conclusion
that Mfn2 is a negative regulator of ER stress required for the
homeostasis of the ER (Ngoh et al., 2012).
Even if the mechanism is not fully understood, Mfn2 is
also involved in cardiac autophagic processes (Zhao et al.,
2012). These authors showed that Mfn2 could participate in
autophagosome-lysosome fusion. Due to the presence of Mfn2
in the ER and thus autophagosome membrane, it might act as
an adaptor protein mediating autophagosome maturation. This
link between Mfn2 and autophagy is reminiscent of the fact that
mitochondrial dynamics proteins are also major actors of selec-
tive mitochondrial autophagy, i.e., mitophagy. Indeed, it is largely
admitted that selective clearance of mitochondria are preceded
by fission phenomena (Twig et al., 2008b). In fact, in the early
event of mitophagy, Drp1 is recruited to mitochondria (Lee et al.,
2011) and Mfns, present at the membrane of damaged mito-
chondria, are rapidly ubiquitined (Ziviani et al., 2010). This Mfns
ubiquitination could thus address these proteins to the protea-
some or could interfere with mitochondrial tethering and prevent
altered mitochondria to join the mitochondria network (Ziviani
and Whitworth, 2010). Besides, in addition to the low mitochon-
drial potential allowing identification of mitochondria destined
to mitophagy, these mitochondria would exhibit a low Opa1
amount at the inner membrane (Twig et al., 2008a). This cre-
ates non-fusing mitochondria which thus have only one destiny:
degradation.
Finally, changes in the components of mitochondrial dynamics
can also alter mtDNA. Observations in S. cerevisiae andMEF cells
indicate that the normal activity of Opa1 (Jones and Fangman,
1992; Guan et al., 1993; Chen et al., 2007) or Mfns (Hermann
et al., 1998; Rappaport et al., 1998; Chen et al., 2003, 2007) are
crucial for maintaining the integrity of mtDNA nucleoids (Liesa
et al., 2009). Part of Opa1 could be involved in the attachment of
mtDNA to the inner mitochondrial membrane and to promote
mtDNA replication and distribution (Elachouri et al., 2011). In
the mature heart, one study reported that heterozygous Opa1+/−
mice exhibit reduced mtDNA copy number (Chen et al., 2012),
which could be involved in the development of cardiac mitochon-
drial dysfunction.
Finally, even if the number of studies devoted to the role of
mitochondrial dynamics proteins in the heart is limited (Table 1),
it can be asserted that these proteins are clearly integral part
of cardiomyocyte life by ensuring fusion/fission processes and
by participating in the several mechanisms described above.
Interestingly, it seems that these proteins would be particularly
important under stress conditions which are known to mobilize
or affect mitochondrial functions. These kinds of situations exac-
erbate mitochondrial biogenesis and turnover which are relatively
low under basal conditions, showing the major significance of the
processes governed by these proteins in cardiac adaptations.
ALTERATIONS OF MITOCHONDRIAL DYNAMICS IN CARDIAC
PATHOLOGIES AND POSSIBLE THERAPEUTIC APPROACHES
Chronic HF is associated with morphologic abnormalities of
cardiac mitochondria including increased number, reduced
organelles size, and compromised structural integrity (Schaper
et al., 1991; Sabbah et al., 1992; Beutner et al., 2001), suggest-
ing fragmentation of the mitochondrial network (Joubert et al.,
2008). Mitochondrial damages as the depletion of the mitochon-
drial matrix and disruption of membranes positively correlate
with the HF severity index (Sabbah et al., 1992) and it is recog-
nized that mitochondria can determine the cellular fate (Di Lisa
and Bernardi, 1998). In other pathologies, mega-mitochondria
can appear (for review, see Wakabayashi, 2002 and Hoppel et al.,
2009). Most of the time, heterogeneity of the size and distribution
of cardiac mitochondria increases in HF, evidencing unbalanced
fusion/fission cycles. Thus, an emerging hypothesis is that the
mechanisms that control the shape of mitochondria may play a
role in cardiac pathologies. In particular, a recent study suggested
that Opa1 could be downregulated in HF (Chen et al., 2009;
Chen and Knowlton, 2010). Another study observed a decrease in
Mfn2, an increase in Fis1, and no change in Opa1 expression in
rat hearts 12–18 weeks after myocardial infarction (Javadov et al.,
2011). However, alteration of dynamin proteins could merely be
the consequence of the alteration of mitochondrial biogenesis as
it has been suggested (Garnier et al., 2005; Ventura-Clapier et al.,
2011). Indeed, a strict relation exists between the PPAR gamma
coactivator-1 (PGC-1α), a master regulator of mitochondrial bio-
genesis, and the expression of these proteins (Garnier et al., 2005).
Moreover, in most cardiac pathologies where defect in dynamin
proteins are observed, a decrease in mitochondrial mass is also
present (Ventura-Clapier et al., 2011; Parra et al., 2011). So it
is not clear so far which protein alteration is responsible for a
possible unbalance in fusion/fission, and the post-translational
modifications of, for example, Drp1 (see above) could also be
involved. Similarly, nothing is known about a possible implication
of GTP/GDP supply in mitochondrial dynamics regulation.
Cell death is also an important pathophysiological process
in both HF and in cardiac ischemia. However, the underlying
mechanisms by which the heart looses myocytes in HF are not
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Table 1 | Mitochondrial dynamic studies on the mature heart.
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completely understood. Mitochondria have a critical role in reg-
ulating cardiac cell death. If fission is interrupted, large networks
of fusedmitochondria occur. If fusion fails, mitochondria become
smaller and fragmented. Abnormalities in fission and fusion can
lead to apoptosis (Lee et al., 2004; Cassidy-Stone et al., 2008)
which is an important mechanism of cardiac myocyte loss in
HF (Olivetti et al., 1997; Narula et al., 1999). So both HF and
ischemia could be associated with abnormalities of fission and
fusion that would contribute to cardiac cell death and change
of MPTP sensitivity. In particular, after ischemia-reperfusion,
mitochondria of cardiomyocytes show heterogeneous damages
in their morphology, in redox status and in calcium homeosta-
sis, which could be related to an overproduction of local ROS
(Ong et al., 2012).
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Modulation of mitochondrial dynamics appears as a novel
pharmacological strategy for cardioprotection, in particular to
protect the heart after a heart attack, and in ischemia-reperfusion
[see reviews by Ong et al. (2012) and Dorn (2013)]. Several
studies have shown that changes in mitochondrial morphol-
ogy, including targeting proteins of the mitochondrial dynamics
could allow the heart to better recover from an ischemic insult
(Ong et al., 2010; Papanicolaou et al., 2011). In the first study,
the authors used a specific inhibitor of Drp1, Mdiv-1, to pre-
vent mitochondrial fission, and observed a significant reduction
in myocardial infarct size in the in vivo murine heart. In the
second one, using a genetic model of Mfn2 KO mice, they
observed an improvement of cardiac performance following ex
vivo ischemia/reperfusion. In both cases, even if the strategy was
different (decrease the fission in one case, decrease the fusion in
the second case), they linked the protection to the inhibition of
MPTP opening, which is a classical target of cardioprotection.
However, it should be kept in mind that although inhibition of
MPTP can be beneficial in short term, it could be detrimental on
the long term (Elrod et al., 2010; Piquereau et al., 2012).
CONCLUSION
Generally, studies described above prove that mitochondrial
dynamics proteins are necessary for normal mitochondrial func-
tions in the cardiomyocyte. In this cell where the internal orga-
nization is an obstacle to organelles mobility, these proteins
govern slow fusion/fission processes which ensure mitochon-
drial turnover required to maintain mitochondrial function and
consequently organ function. It also seems that mitochondrial
dynamics would be a key element of cardiomyocyte adapta-
tion under stress which induce alteration of mitochondria and
thus lead to generation of new mitochondria and degradation
of damaged mitochondria. Under such conditions, mitochon-
drial dynamics processes would be exacerbated andwould assume
greater significance, explaining why the genetically-manipulated
mice for mitochondrial dynamics genes are particularly sensi-
tive to stress. Therefore, the high expression level of dynamins
under basal conditions, despite the slow fusion/fission cycle,
could be a major element of cardiac adaptation. In addition,
those proteins could be activated by post-translational modifi-
cations involved in signaling pathways activated in response to
stress. It can be anticipated that those potential post-translational
modifications would be the more efficient way to ensure an
optimal reactivity of mitochondrial dynamics machinery under
stress.
Finally, mitochondrial dynamics proteins are involved in sev-
eral phenomena irrespectively of their role in mitochondrial
dynamics. This aspect of these dynamins has to be kept in mind
because they are essential for the adequate function of mitochon-
dria and cell life. By their extended field of action, these proteins
are clearly established asmajor components of cardiac physiology.
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